Abstract
Measles, mumps and rubella are acute infectious diseases caused by viral infections in children and caused great harm before the use of vaccines. The Measles, Mumps and Rubella (MMR) oral vaccine indicates a breakthrough in the fight against three infectious diseases which are measles, mumps and rubella. Unlike the traditional injectable MMR vaccine. This oral vaccine does not require an injection, and it can improve patient acceptance. The purpose of this paper is to provide a comprehensive study of the development, efficacy and safety of the oral MMR vaccine and compare it with the traditional injectable vaccine. It will emphasize the benefits of oral vaccines, such as reduced needle-related fears and increased accessibility, which are particularly beneficial in resource-limited settings where needle vaccination may be impractical. In addition, this paper will discuss the challenges of maintaining vaccine stability, dosage accuracy, vaccine efficacy and safety. Through these analyses, this paper seeks to determine whether oral MMR vaccine can be a viable alternative to global immunization efforts.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call